Quanhe Yang

Quanhe Yang

Auto-generated profile, based on publicly available information

Quanhe Yang

From the Division for Heart Disease and Stroke Prevention, Centers for Disease Control and Prevention, Atlanta, GA

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2014 in JAMA Internal Medicine
Verified
Journal Article
Open access
PDF file
QYQuanhe Yang
Quanhe Yang
ZZZefeng Zhang
Zefeng Zhang
EGEdward W. Gregg
Edward W. Gregg
WFW. Dana Flanders
W. Dana Flanders
RMRobert Merritt
Robert Merritt
FHFrank B. Hu
Frank B. Hu
Consumption of added sugar, including all sugars added in processing or preparing foods, among Americans aged 2 years or older increased from an average of 235 calories per day in 1977-1978 to 318 calories per day in 1994-1996. This change was mainly attributed to the increased consumption of sugar-sweetened beverages.1 Although the absolute and percentage of daily calories derived from added sugars declined between 1999-2000 and 2007-2008, consumption of added sugars remained high in US diets, especially among children.2 Recommendations for added sugar consumption vary substantially. The Institute of Medicine recommends that added sugar make up less than 25% of total calories,3 whereas the World Health Organization recommends less than 10%.4 The American Heart Association recommends limiting added sugars to less than 100 calories daily for women and 150 calories daily for men.5 The 2010 Dietary Guidelines for Americans6 recommend limiting total intake of discretionary calories, which include added sugars and solid fats, to 5% to 15% of daily caloric intake. Randomized clinical trials and epidemiologic studies have shown that individuals who consume higher amounts of added sugar, especially sugar-sweetened beverages, tend to gain more weight7 and have a higher risk of obesity,2,8-13 type 2 diabetes mellitus,8,14-17 dyslipidemias,18,19 hypertension,20,21 and cardiovascular disease (CVD).14,22 Most previous studies have focused on sugar-sweetened beverages but not total added sugar, and none of these studies has used nationally representative samples to examine the relationship between added sugar intake and CVD mortality.

16 March 2012 in JAMA
Verified
Journal Article
Open access
PDF file
QYQuanhe Yang
Quanhe Yang
MCMary E. Cogswell
Mary E. Cogswell
WFW. Dana Flanders
W. Dana Flanders
YHYuling Hong
Yuling Hong
ZZZefeng Zhang
Zefeng Zhang
FHFrank B. Hu
Frank B. Hu
Cardiovascular disease (CVD) is the leading cause of deaths in the United States (>800 000, or about 1 in 3 overall deaths/y),1 with estimated annual direct and overall costs of $273 billion and $444 billion, respectively.2 Previous epidemiologic studies indicate that individuals who meet an increased number of cardiovascular health behaviors or factors (such as not smoking and achieving normal blood pressure, blood glucose level, and weight) have a significantly reduced risk of CVD incidence and mortality.3-9 Achieving and maintaining cardiovascular health behaviors and factors in individuals and communities could have significant effects on reducing CVD incidence and mortality at the population level.

11 July 2011 in Archives of internal medicine (1960)
Verified
Journal Article
Open access
PDF file
QYQuanhe Yang
Quanhe Yang
TLTiebin Liu
Tiebin Liu
EKElena V. Kuklina
Elena V. Kuklina
WFW. Dana Flanders
W. Dana Flanders
YHYuling Hong
Yuling Hong
FHFrank B. Hu
Frank B. Hu
Quiz Ref ID Randomized controlled trials (RTCs) and epidemiologic studies have shown that individuals with higher sodium or lower potassium intakes have increased risk for elevated blood pressure and hypertension.1-8 Although elevated blood pressure and hypertension are associated with increased risk for cardiovascular diseases (CVDs), the observed association between sodium or potassium intake and CVD incidence or mortality has been inconsistent.4,9-12 Recently, several studies suggested that the ratio of sodium to potassium intakes represented a more important risk factor for hypertension and CVD than each factor alone.3,11-14

14 March 2006 in Circulation
Verified
Journal Article
Closed access
QYQuanhe Yang
Quanhe Yang
LBLorenzo D. Botto
Lorenzo D. Botto
JEJ. David Erickson
J. David Erickson
RBRobert Berry
Robert Berry
CSChristie Sambell
Christie Sambell
JFJan M Friedman
Jan M Friedman
Background— In the United States and Canada, folic acid fortification of enriched grain products was fully implemented by 1998. The resulting population-wide reduction in blood homocysteine concentrations might be expected to reduce stroke mortality if high homocysteine levels are an independent risk factor for stroke. Methods and Results— In this population-based cohort study with quasi-experimental intervention, we used segmented log-linear regression to evaluate trends in stroke-related mortality before and after folic acid fortification in the United States and Canada and, as a comparison, during the same period in England and Wales, where fortification is not required. Average blood folate concentrations increased and homocysteine concentrations decreased in the United States after fortification. The ongoing decline in stroke mortality observed in the United States between 1990 and 1997 accelerated in 1998 to 2002 in nearly all population strata, with an overall change from −0.3% (95% CI, −0.7 to 0.08) to −2.9 (95% CI, −3.5 to −2.3) per year ( P =0.0005). Sensitivity analyses indicate that changes in other major recognized risk factors are unlikely to account for the reduced number of stroke-related deaths in the United States. The fall in stroke mortality in Canada averaged −1.0% (95% CI, −1.4 to −0.6) per year from 1990 to 1997 and accelerated to −5.4% (95% CI, −6.0 to −4.7) per year in 1998 to 2002 ( P ≤0.0001). In contrast, the decline in stroke mortality in England and Wales did not change significantly between 1990 and 2002. Conclusions— The improvement in stroke mortality observed after folic acid fortification in the United States and Canada but not in England and Wales is consistent with the hypothesis that folic acid fortification helps to reduce deaths from stroke.

17 September 2012 in Pediatrics
Verified
Journal Article
Closed access
PDF file
QYQuanhe Yang
Quanhe Yang
ZZZefeng Zhang
Zefeng Zhang
EKElena V. Kuklina
Elena V. Kuklina
JFJing Fang
Jing Fang
CACarma Ayala
Carma Ayala
RMRobert Merritt
Robert Merritt
To assess the association between usual dietary sodium intake and blood pressure among US children and adolescents, overall and by weight status. Children and adolescents aged 8 to 18 years (n = 6235) who participated in NHANES 2003–2008 comprised the sample. Subjects’ usual sodium intake was estimated by using multiple 24-hour dietary recalls. Linear or logistic regression was used to examine association between sodium intake and blood pressure or risk for pre-high blood pressure and high blood pressure (pre-HBP/HPB). Study subjects consumed an average of 3387 mg/day of sodium, and 37% were overweight/obese. Each 1000 mg per day sodium intake was associated with an increased SD score of 0.097 (95% confidence interval [CI] 0.006–0.188, ∼1.0 mm Hg) in systolic blood pressure (SBP) among all subjects and 0.141 (95% CI: –0.010 to 0.298, ∼1.5 mm Hg) increase among overweight/obese subjects. Mean adjusted SBP increased progressively with sodium intake quartile, from 106.2 mm Hg (95% CI: 105.1–107.3) to 108.8 mm Hg (95% CI: 107.5–110.1) overall (P = .010) and from 109.0 mm Hg (95% CI: 107.2–110.8) to 112.8 mm Hg (95% CI: 110.7–114.9; P = .037) among those overweight/obese. Adjusted odds ratios comparing risk for pre-HBP/HPB among subjects in the highest versus lowest sodium intake quartile were 2.0 (95% CI: 0.95–4.1, P = .062) overall and 3.5 (95% CI: 1.3–9.2, P = .013) among those overweight/obese. Sodium intake and weight status appeared to have synergistic effects on risk for pre-HBP/HPB (relative excess risk for interaction = 0.29 (95% CI: 0.01–0.90, P < .05). Sodium intake is positively associated with SBP and risk for pre-HBP/HPB among US children and adolescents, and this association may be stronger among those who are overweight/obese.

25 July 2005 in International Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
QYQuanhe Yang
Quanhe Yang
MKMuin J Khoury
Muin J Khoury
JFJm Friedman
Jm Friedman
Julian LittleJulian Little
Julian Little
WFW Dana Flanders
W Dana Flanders
Background Most common human diseases are due to complex interactions among multiple genetic variants and environmental risk factors. There is debate over whether variants of a relatively small number of genes, each with weak or modest individual effects, account for a large proportion of common diseases in the population, or whether a large number of rare variants with large effects underlie genetic susceptibility to these diseases. It is not clear how many genes are necessary to account for an appreciable population-attributable fraction of these diseases. Methods In this analysis, we estimated the number of disease susceptibility genes needed to account for varying population attributable fractions of a common complex disease, taking into account the genotype prevalence, risk ratios for individual genes, and the model of gene–gene interactions (additive or multiplicative). Results Very large numbers of rare genotypes (e.g. those with frequencies of 1 per 5000 or less) are needed to explain 50% of a common disease in the population, even if the individual risk ratios are large (RR = 10–20). On the other hand, only ∼20 genes are usually needed to explain 50% of the burden of a disease in the population if the predisposing genotypes are common (≥25%), even if the individual risk ratios are relatively small (RR = 1.2–1.5). Conclusions Our results suggest that a limited number of disease susceptibility genes with common variants can explain a major proportion of common complex diseases in the population. Our findings should help focus the search for common genetic variants that provide the most important predispositions to complex human diseases.